Thermo Fisher forges $1.7 billion deal to buy a contract player in the booming gene therapy field →Endpoints News
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025